Randomized Phase 2 Study of Guadecitabine in Patients with HMA-Naive Higher Risk Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Saved in:
Bibliographic Details
Published in:Leukemia research Vol. 55; pp. S40 - S41
Main Authors: Savona, M.R, Garcia-Manero, G, Roboz, G.J, Walsh, K.J, Kropf, P.L, Issa, J.P, O’Connell, C.L, Tibes, R, Yee, K.W.L, Stock, W, Lunin, S, Berdeja, J.G, Naim, S, Hao, Y, Azab, M, Kantarjian, H
Format: Journal Article
Language:English
Published: 01-04-2017
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0145-2126
DOI:10.1016/S0145-2126(17)30173-X